Immunohistochemical results from 173 HNSCC patients suggest that the overexpression of CAV1 may contribute to local recurrence after radiotherapy through the CAV1/Epiregulin (EREG)/yes-associated protein (YAP) pathway [31]. Here, EREG is linked to head and neck squamous cell carcinoma.